Brief: LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets

LianBio

24/10/2023 12:02

Oct 24 (Reuters) - LianBio  LIAN.O :
    * LIANBIO ENTERS INTO AGREEMENT WITH BRISTOL MYERS SQUIBB
FOR
MAVACAMTEN IN CHINA AND OTHER ASIAN MARKETS
    * LIANBIO - LIANBIO TO RECEIVE TOTAL UPFRONT CONSIDERATION
OF $350
MILLION
    * LIANBIO - TO CONDUCT STRATEGIC REVIEW OF BUSINESS
    * LIANBIO - WILL BE RELEASED FROM PAYMENT OBLIGATIONS OF UP
TO
$127.5 MILLION IN REMAINING MILESTONE PAYMENTS UNDER MYOKARDIA
LICENSE AGREEMENT
    * LIANBIO - EXPECTS TO PROVIDE AN UPDATE ON ITS STRATEGIC
REVIEW
IN FIRST HALF OF 2024

Source text for Eikon:  ID:nGNX7yT1bC 
Further company coverage:  LIAN.O 

 ((Reuters.Briefs@thomsonreuters.com;))